Lupin gets FDA nod for generic Prozac

Press enter to search
Close search
Open Menu

Lupin gets FDA nod for generic Prozac

By Sandra Levy - 02/12/2019
Lupin has received the Food and Drug Administration’s blessing for its generic Prozac (fluoxetine tablets), in a 60-mg dosage strength.

It is indicated in the treatment of major depressive disorder, obsessive compulsive disorder, bulimia nervosa, and panic disorder, with or without agoraphobia.

Fluoxetine tablets, 60-mg, had a market value of approximately $42.5 million, according to December 2018 IQVIA data.

 

RELATED TOPICS